|Description||(R)-DPN has been found to be an estrogen receptor (ER) β agonist with higher affinity for estrogen receptor.|
|Purity||≥98% by HPLC|
PPT, also known as Propyl pyrazole triol, is an ERα selective agonist with a 410-fold relative binding affinity for ERα (49%) versus ERβ (0.12%) and therefore a...
Trans-Clomiphene, a stilbenes derivative, has been found to be an estrogen receptor antagonist as well as testosterone agonist. It has been developed for hypogo...
Y 134 is a selective estrogen receptor modulator (SERM) with selectivity for ERα over ERβ (Ki = 0.09 and 11.31 nM, respectively). It has no cross-reactivity wit...
Endoxifen, a significant metamolite of Tamoxifen, is a regulator of estrogen receptor and could be effective in the treatment of estrogen-dependent breast cance...
Ethisterone is a progestogen hormone being considered to treat prostate cancer.It was the first orally-active progestin.
Tamoxifen Citrate is an antagonist of the estrogen receptor by competitive inhibition of estrogen binding, leading to a reduction in DNA synthesis and cellular ...
Panomifene is an Estrogen receptor antagonist under the development of Egis Pharmaceuticals. Phase II clinical trials for the treatment of breast cancer was dis...
SNG-1153, derived from icaritin which is purified from Epimedium Genus, modulates ER-α36 and induces β-catenin phosphorylation and then down-regulates β-catenin...